Because of treatment such as intravenous hyperalimentation many anorectic patients now survive instead of dying from emaciation. Some patients, however, have chronic anorectic symptoms and remain in a prolonged state ofmalnutrition. Bulimic symptoms may emerge later, increasing the person's physiological and nutritional imbalance. The haematological and immunological aspects of anorexia nervosa have been widely investigated,'-5 but to our knowledge a possible connection between eating disorders and leukaemia has not been described. We report on three patients who developed myelocytic leukaemia after protracted eating disorders. None had a history of exposure to excessive radiation or to other potential sources of leukaemig.
Case reports
Case 1-A 20 year old woman, whose body weight had fluctuated from 50 kg in the summer to 60 kg in the winter since she was Neuropsysfiatry, School qE was twice diagnosed as having hypokalaemia and anaemia. When 24 years old she noticed prolonged menstrual bleeding. Acute myeloblastic leukaemia (French-American British classification, MI type) was diagnosed, and she underwent chemotherapy.
Comment
According to the Ministry of Health and Welfare, the mortality from leukaemia in Japan was 1 2/100 000 women aged 20-24 in 1992. Although this is not the prevalence, the figure indicates the rarity of the illness. The patients described in cases 1 and 2 were among 89 patients with eating disorders who were referred to us for psychiatric research on eating disorders. The prevalence of leukaemia among patients with eating disorders seems higher than that in the general population.
We do not suggest that a specific relation exists between a type of eating disorder and a type of leukaemia, but a protracted malnutritional state may affect general systems such as the immune system. Some research suggests that cellular immunity is decreased in patients with eating disorders, ' Instructions to authors
General points * All material submitted for publication is assumed to be submitted exclusively to the BMJ unless the contrary is stated and should conform to the uniform requirements for manuscripts submitted to biomedical journals (the Vancouver style; BMJ 1991;302:338-41). * All authors must give signed consent to publication. * The editor retains the customary right to style and if necessary shorten material accepted for publication. * Type all manuscripts (including letters and obituaries) in double spacing with 5 cm margins. * Number the pages. * Give the name and address of the author to whom correspondence and proofs should be sent. * Do not use abbreviations. * Express all scientific measurements (except blood pressure) in SI units. * Keep one copy of the manuscript for reference. * Send three copies (if the paper is rejected these will not be returned; after three months they will be shredded). * Whenever possible give numbers of patients or subjects studied (not percentages alone). * Any article may be submitted to outside peer review and assessment by the editorial committee as well as statistical assessment; this takes about eight weeks. * Manuscripts are usually published within three months of the date of final acceptance. LEERS * Should normally be a maximum of 400 words and five references. * Must be signed by all the authors. * Only one copy should be sent. * Preference is given to those that take up points made in articles published in the joumal. * Authors do not receive proofs. 
